Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease

J Am Coll Cardiol. 1993 Nov 1;22(5):1344-53. doi: 10.1016/0735-1097(93)90541-8.

Abstract

Objectives: The aim of this study was to determine whether patients with ventricular arrhythmias in the absence of coronary artery disease also have abnormalities in sympathetic innervation.

Background: We have previously shown by cardiac sympathetic scintigraphy using iodine-123-metaiodobenzylguanidine (I-123-MIBG) that patients with ventricular tachycardia after myocardial infarction have regional cardiac sympathetic denervation. It is not known whether patients with ventricular tachycardia in the absence of coronary artery disease also have regional cardiac sympathetic denervation.

Methods: We performed cardiac I-123-MIBG and thallium-201 single-photon emission computed tomographic (SPECT) scans at rest in 18 patients (mean age 47 +/- 18 years) with cardiomyopathy (n = 6), left ventricular hypertrophy (n = 1), valvular disease (n = 2) or a structurally normal heart (n = 9) who presented with monomorphic (n = 15) or polymorphic (n = 3) ventricular tachycardia. These scans were compared with scans in 12 control patients without ventricular tachycardia (mean age 30 +/- 17 years) who had cardiomyopathy (n = 3) or a structurally normal heart (n = 9). Cardiac sympathetic denervation was defined as myocardial areas having thallium uptake with reduced or absent I-123-MIBG uptake.

Results: Twelve (67%) of 18 patients with ventricular tachycardia had regional cardiac sympathetic denervation compared with 1 (8%) of 12 patients who did not have ventricular tachycardia (p = 0.002). In the nine patients with a structurally normal heart and ventricular tachycardia, five (55%) patients had regional cardiac sympathetic denervation compared with zero of nine control patients with a structurally normal heart (p = 0.029). Five patients underwent right ventricular radiofrequency ablation for ventricular tachycardia, and sympathetic denervation was adjacent to the ablation site in one of these patients.

Conclusions: Patients with ventricular tachycardia in the absence of coronary artery disease have abnormal cardiac sympathetic innervation detectable by cardiac sympathetic scintigraphy. The role of regional cardiac sympathetic denervation in arrhythmogenesis remains to be determined.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3-Iodobenzylguanidine
  • Adolescent
  • Adult
  • Aged
  • Autonomic Nervous System Diseases / complications*
  • Autonomic Nervous System Diseases / diagnostic imaging
  • Cardiac Catheterization
  • Cardiomyopathies / complications*
  • Cardiomyopathies / diagnostic imaging
  • Case-Control Studies
  • Catheter Ablation
  • Child
  • Echocardiography
  • Electrophysiology
  • Exercise Test
  • Female
  • Heart Valve Diseases / complications*
  • Heart Valve Diseases / diagnostic imaging
  • Humans
  • Hypertrophy, Left Ventricular / complications*
  • Hypertrophy, Left Ventricular / diagnostic imaging
  • Iodine Radioisotopes
  • Iodobenzenes
  • Male
  • Middle Aged
  • Sympathetic Nervous System*
  • Tachycardia, Ventricular / classification
  • Tachycardia, Ventricular / diagnosis
  • Tachycardia, Ventricular / etiology*
  • Tachycardia, Ventricular / surgery
  • Thallium Radioisotopes
  • Tomography, Emission-Computed, Single-Photon

Substances

  • Iodine Radioisotopes
  • Iodobenzenes
  • Thallium Radioisotopes
  • 3-Iodobenzylguanidine